Kenyan Runner Ekiru Receives 10 Years Doping Ban

17 October 2023

Kenyan marathon runner Titus Ekiru has been banned for 10 years, the Athletics Integrity Unit (AIU) said Monday, for both doping and tampering in a case that involved collusion with a high-ranking doctor in a Kenyan hospital.

One of his positive tests, for triamcinolone acetonide, came at the Milan Marathon in May 2021, which he won in a time of two hours, two minutes and 57 seconds, which would currently rank him the seventh-fastest all-time marathon athlete.

The ban comes after an investigation found the 31-year-old obstructed the AIU's probe into two adverse analytical findings (AAFs) by using false information and documentation.

His ban runs from the date of his provisional suspension on June 28, 2022 until June 27, 2032. His results on and since May 16th, 2021 have been erased and he must forfeit all race prizes and money.

Ekiru also tested positive after winning the Abu Dhabi Marathon on Nov. 26th for pethidine and its marker norpethidine.

An investigation showed Ekiru received injections of banned substances during undocumented hospital visits, and the AIU was able to determine medical documents submitted to explain his AAFs were forged and inconsistent with hospital and pharmacy records.

"For athletes involved in doping and the entourage who assist them, there is one strong message from this case - there is nowhere to hide," said AIU chair David Howman.

AllAfrica publishes around 600 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.